Session

IBD II

DIFFERENT INFLAMMASOME TYPES COLLABORATE IN HUMAN INFLAMMATORY BOWEL DISEASES

Dominiek Staelens, Paul Peeters, Jan van der Goten, Emiel F.M. Wouters, Gert Van Assche, Marc Ferrante, Severine Vermeire, Paul Rutgeerts, Kris Nys, Ingrid Arijs

DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING IN CROHN'S DISEASE: VALIDATION OF QUANTITATIVE INDEX OF ACTIVITY

Anthony Buisson, Julien Scanzi, Félix Goutorbe, Bruno Simões Pereira, Corinne Borderon, Gilles Bommelaer, Virginie Petitcolin

DISTINCT CELL SIGNALLING MECHANISMS DRIVE THE TUMOUR NECROSIS FACTOR ALPHA AND INTERFERON GAMMA-INDUCED TRANSCRIPTIONAL DOWNREGULATION OF AQUAPORIN 3 RNA EXPRESSION

Michael Augustyn Peplowski, Andrew Joseph Vegso, Wallace Keith MacNaughton

DISTRIBUTION OF DIAGNOSTIC CRITERIA FOR COLLAGENOUS COLITIS – POOLED ANALYSIS OF 2 EUROPEAN CLINICAL TRIALS

Stephan Miehlke, Daniela Aust, Ole Kristian Bonderup, Johan Bohr, Ahmed Madisch, Michael Vieth, Henrik Hjortswang, Fernando Fernández-Bañares, Curt Tysk, Magnus Strom, Ralph Mueller, Roland Greinwald, Andreas Münch, Ralf Mohrbacher

BODY COMPOSITION IN CROHN`S DISEASE PATIENTS BUT NOT IN ULCERATIVE COLITIS PATIENTS IS DIFFERENT COMPARED TO HEALTHY CONTROLS

Chritstoph Dölger, Hermann Schulze, Juliane Thieringer, Jürgen Stein, Axel Dignass

CD80 SIGNALING MANIPULATION AFFECTS TUMOR IMMUNOSURVEILLANCE IN EXPERIMENTAL COLITIS-ASSOCIATED CANCER

Marco Scarpa, Paola BRUN, Ignazio CASTAGLIUOLO, Susan Morgan, Melania Scarpa, Andromachi Kotsafti, Renata D'Incà, Andrea Buda, Carlo Castoro, Giacomo Carlo Sturniolo, Imerio Angriman

AZATHIOPRINE ACHIEVES MUCOSAL HEALING IN PATIENTS WITH EARLY-ONSET CROHN’S DISEASE

Kostas Papamichael, Emmanouil Archavlis, Pantelis Karatzas, Xanthipi Tzanetakou, Iosif Internos, Stylianos Anastasiadis, Nikolaos Kyriakos, Dimitrios Tsironikos, Gerassimos J. Mantzaris

CIRCULATING B CELL SUBSETS CORRELATE WITH CLINICAL RESPONSE TO ANTI-TNF THERAPY IN IBD

Zhe Li, Severine Vermeire, Dominique Bullens, Marc Ferrante, Kristel Van Steen, Maja Noman, Paul Rutgeerts, Jan L. Ceuppens, Gert Van Assche

ANORECTAL COMPLICATIONS AND FUNCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: 14 YEARS FOLLOW-UP

Tze J. Lam, Chris J.J. Mulder, Adriaan van Bodegraven, Richelle Felt-Bersma

CLINICAL PHARMACOLOGY, SAFETY, AND EFFECTS OF ANTI-IL-23 ANTIBODY AMG 139

Wei-Jian Pan, William Rees, Jennifer Towne, John Gibbs, Alexander Colbert, Theresa Goletz, Kathryn Newhall, Kefei Zhou, Samantha Prokop, Amber Umble-Romero, Christina Krill, Ping-Cheng Yi, Nathan Standifer, Jonathan Lee, George Hodsman, Jason Lickliter, John Wishart, Sepehr Shakib, Catherine Reid, Joanne Marjason, Chris

Item 1 - 10 / 100
1
2 3 4 5 6 7 8 9 10